Find a Tender
complete
Official procurement procedure
NCA21150 - Scalable Transfection System
Medical equipments
Medical equipments
pharmaceuticals and personal care products
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: University Of Edinburgh: "NCA21150 - Scalable Transfection System". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | University Of Edinburgh | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: University Of Edinburgh
Market Analytics
Derived from OCDS awards & bid statistics
Published history for University Of Edinburgh. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
3.3Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 230 active published awards; 205 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityUniversity Of Edinburgh | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSNot published | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published2 Feb 2023, 09:42 GMT | Last source update2 Feb 2023, 09:42 GMT | Recurring procurementNot published |
ClassificationMedical equipments, Medical equipments, pharmaceuticals and personal care products | ||
Delivery area | ||
OCIDocds-h6vhtk-03a23d | ||
What is being bought
a validated platform for cell transfection using
flow electroporation. The system enables rapid and efficient transfection of any kind of cell with any
molecule (plasmids, proteins, protein complexes, drugs, mRNA, siRNA) at any scale. The sterile, closed
system provides consistency, flexibility, scalability and loading efficiency while avoiding the
inherent drawbacks of alternative methods
What changed
From the official release history
- Status changed to complete
2 Feb 2023, 09:42 GMT - Official notice release published
2 Feb 2023, 09:42 GMT - Buyer information updated
2 Feb 2023, 09:42 GMT
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcancelledPublished valueNot publishedThe MaxCyte ExPERT GTx is the only instrument available on the market that can perform transfection of human cells at a scale compatible with large-scale genome engineering applications: up to 20 billion cells per experiment. The MaxCyte offers high efficiency of electroporation, low cytotoxicity and high flexibility through its unique flow electroporation technology, in which cells are pumped through an integrated electroporation circuit. Competing instruments that lack the flow electroporation capacity are not compatible with large-scale genome engineering applications.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
2 Feb 2023, 09:42 GMT - Award active
Not published · Not published - Contract active
Signed 16 Dec 2022, 00:00 GMT · £115,993
Commercial outcome and competition
Awards MaxCyte Not published · Not published · active |
Contracts Contract £115,993 · signed 16 Dec 2022, 00:00 GMT · active |
Bid statistics bids: 1 (lot 1) electronicBids: 1 (lot 1) foreignBidsFromEU: 0 (lot 1) foreignBidsFromNonEU: 1 (lot 1) smeBids: 0 (lot 1) |
Buyer and organisations in this procedure
University Of Edinburgh
Contracting authority GB-FTS-2023Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published
Planning and rationale
Planning budgetNot published |
No-engagement rationaleNot published |
Procedure rationaleThe MaxCyte ExPERT GTx is the only instrument available on the market that can perform transfection of human cells at a scale compatible with large-scale genome engineering applications: up to 20 billion cells per experiment. |